Investors looking for U.S. small-cap equity exposure often compare IJR and IWM. Both are passively managed funds from BlackRock that launched on the same day in May 2000, yet they follow slightly different approaches. This comparison feels especially relevant now amid shifting rate expectations and sector rotation. The funds compete for broad small-cap exposure but differ in index construction, quality screens, costs, and diversification — differences that can influence positioning and long-term results.
IJR aims to track the S&P SmallCap 600 Index, a market-cap-weighted benchmark focused on the smaller end of the U.S. equity market. A key feature is the index’s profitability screen, which generally requires positive earnings and filters out many unprofitable or speculative companies. The fund holds roughly 640 to 650 stocks, and because it is cap-weighted, no single holding dominates; top positions each make up well under 1% of assets. Recent top names include FORM, VSAT, QRVO, MTCH, PTGX, GKOS, and PAYC.
Sector allocation is fairly balanced, led by financials (roughly 17%), industrials (about 16%), information technology (near 15%), consumer discretionary, and health care. The expense ratio stands at a low 0.06%, and the fund uses physical, full-replication investing. The profitability filter and modestly mid-cap-tilted makeup have historically supported lower volatility and a steadier return profile than the broader small-cap universe. I also checked this using Tickeron’s AI Screener to see how the fund compares to peers on trend and volatility metrics.
IWM tracks the Russell 2000 Index, a float-adjusted, market-cap-weighted measure of the roughly 2,000 smallest companies in the broader Russell 3000 Index. Unlike the S&P SmallCap 600, the Russell 2000 has no profitability requirement, so it includes a substantial share of unprofitable and early-stage businesses. The fund holds close to 2,000 stocks, offering the broadest, most liquid representation of U.S. small caps. Its top positions are even more dispersed, with each typically below 0.5% of assets. Recent top holdings include FROG, BTSG, TWST, UMBF, and GKOS.
Sector exposure concentrates in health care (roughly 18–20%), financials and industrials (each near 16–18%), and information technology (about 15%). IWM carries a higher expense ratio of 0.19% and a higher beta, reflecting its inclusion of smaller, less profitable, and more economically sensitive companies.
The small-cap segment has been shaped in recent market cycles by interest-rate paths, the strength of the domestic economy, and investor appetite for risk. Smaller companies tend to be more sensitive to borrowing costs and domestic demand than large-cap peers, which makes sector exposure in these funds a key driver. A rotation toward domestically oriented, cyclically sensitive businesses has periodically favored small caps, while concerns about unprofitable, cash-burning growth names have at times weighed on the broader Russell 2000 universe. Regulatory developments in financials and health care — two of the largest weightings in both funds — remain important catalysts. The main risk across the segment is a slowdown in U.S. economic growth or a reversal in risk sentiment, which historically hits smaller, lower-quality companies hardest.
In recent weeks and months, both funds have participated in the small-cap recovery, but their relative positioning has diverged. IJR, with its profitability screen and heavier tilt toward financials and industrials, has generally shown lower volatility and more consistent trend behavior. IWM, by contrast, carries a higher beta and greater exposure to unprofitable and micro-cap names, which can amplify both upside and downside during risk-on and risk-off periods. Sector rotation into value and cyclical industries has tended to support IJR’s composition, while IWM’s larger health care and growth-leaning holdings have made it more sensitive to shifts in rate expectations and earnings durability. Overall, IJR has offered a steadier quality-tilted profile, whereas IWM provides broader, more aggressive beta within the small-cap segment. From what I see, the quality bias in IJR stands out when evaluating risk-adjusted outcomes.
When comparing funds like these, I often rely on Tickeron’s AI Screener to quickly assess relative momentum, trend consistency, and risk factors across similar ETFs. The tool lets me apply customizable filters for technical patterns, fundamentals, and performance metrics, which helps surface data-driven insights more efficiently than manual review alone. In my view, this kind of AI-assisted screening adds a useful layer when weighing structural differences between IJR and IWM.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
IJR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 46 instances where the indicator turned negative. In 40 of the 46 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 87%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IJR as a result. In 83 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
IJR moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IJR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The RSI Indicator entered the oversold zone -- be on the watch for IJR's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for IJR crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.
Following a +3.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where IJR advanced for three days, in 240 of 290 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
IJR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 213 of 265 cases where IJR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows